title: The inhibition of oxygen radical release from human neutrophils by resting platelets is reversed by administration of acetylsalicylic acid or clopidogrel.
abstract: Resting platelets inhibit oxygen radical release from neutrophils. Antiplatelet therapy may support this function by preventing platelet activation. Whether antiplatelet agents affect the antioxidative action of resting platelets in the absence of platelet activation is unknown. The effect of acetylsalicylic acid or clopidogrel administration on the antioxidative action of resting platelets was therefore studied in ten healthy volunteers. Preparations of resting platelets were obtained from 5 subjects each - before, during and after an eight-day course of daily treatment with 100 mg of acetylsalicylic acid or 75 mg of the thienopyridine clopidogrel. Human peripheral blood neutrophils were pretreated with the platelets at a ratio of (1/5)0 for 45 min; then formyl-Met-Leu-Phe-triggered oxygen radical release was measured fluorometrically. The inhibitory effect of platelets on oxygen radical release from neutrophils which was seen before treatment was abolished by antiplatelet therapy with either of the drugs, and inhibition was restored gradually after discontinuing acetlsalicylic acid/ clopidogrel intake. Results suggest that the protective role of resting platelets in controlling oxygen radical release from neutrophils in the absence of platelet activation may be impaired by antiplatelet therapy.
authors.affiliation: Medical Intensive Care Unit, Division of General Internal Medicine, Department of Medicine, University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
authors.forename: C M
authors.initials: CM
authors.lastname: Reinisch
authors.forename: S
authors.initials: S
authors.lastname: Dunzendorfer
authors.forename: C
authors.initials: C
authors.lastname: Pechlaner
authors.forename: G
authors.initials: G
authors.lastname: Ricevuti
authors.forename: C J
authors.initials: CJ
authors.lastname: Wiedermann
mesh_terms: D000328:Adult; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000378:metabolism*; D019069:Cell Respiration / Q000187:drug effects; D002478:Cells, Cultured; D000077144:Clopidogrel; D005260:Female; D005609:Free Radicals / Q000378:metabolism*; D006801:Humans; D008297:Male; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D010100:Oxygen; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D005609:Free Radicals; D010975:Platelet Aggregation Inhibitors; D009240:N-Formylmethionine Leucyl-Phenylalanine; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin; D010100:Oxygen